These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
439 related items for PubMed ID: 18060709
1. Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats. Xu M, Wang G, Xie H, Huang Q, Wang W, Jia Y. J Ethnopharmacol; 2008 Feb 12; 115(3):483-8. PubMed ID: 18060709 [Abstract] [Full Text] [Related]
2. Rapid determination and pharmacokinetics study of lignans in rat plasma after oral administration of Schisandra chinensis extract and pure deoxyschisandrin. Mao S, Zhang H, Lv L, Zhu Z, Zhao L, Zhang G, Chai Y. Biomed Chromatogr; 2011 Jul 12; 25(7):808-15. PubMed ID: 20872910 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of Schizandrin and Its Pharmaceutical Products Assessed Using a Validated LC-MS/MS Method. Li CL, Cheng YY, Hsieh CH, Tsai TH. Molecules; 2018 Jan 15; 23(1):. PubMed ID: 29342955 [Abstract] [Full Text] [Related]
4. CYP3A catalyses schizandrin biotransformation in human, minipig and rat liver microsomes. Cao YF, Zhang YY, Li J, Ge GB, Hu D, Liu HX, Huang T, Wang YC, Fang ZZ, Sun DX, Huo H, Yin J, Yang L. Xenobiotica; 2010 Jan 15; 40(1):38-47. PubMed ID: 20001672 [Abstract] [Full Text] [Related]
5. Gender-dependent pharmacokinetics of lignans in rats after single and multiple oral administration of Schisandra chinensis extract. Xu H, Gan J, Liu X, Wu R, Jin Y, Li M, Yuan B. J Ethnopharmacol; 2013 May 02; 147(1):224-31. PubMed ID: 23501155 [Abstract] [Full Text] [Related]
6. Pharmacokinetics and liver uptake of three Schisandra lignans in rats after oral administration of liposome encapsulating β-cyclodextrin inclusion compound of Schisandra extract. Ding Z, Xiao J, Zhang Y, Jiang Y, Chen W, Hu J, Guo Y, Zhang B. J Liposome Res; 2019 Jun 02; 29(2):121-132. PubMed ID: 30821573 [Abstract] [Full Text] [Related]
7. Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis extracts) by self-emulsifying drug delivery systems. Shao B, Tang J, Ji H, Liu H, Liu Y, Zhu D, Wu L. Drug Dev Ind Pharm; 2010 Nov 02; 36(11):1356-63. PubMed ID: 20849350 [Abstract] [Full Text] [Related]
8. A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats. Zhan S, Guo W, Shao Q, Fan X, Li Z, Cheng Y. J Ethnopharmacol; 2014 Mar 14; 152(2):333-9. PubMed ID: 24462784 [Abstract] [Full Text] [Related]
9. Determination of deoxyschizandrin in rat plasma by LC-MS. Deng X, Chen X, Yin R, Shen Z, Qiao L, Bi K. J Pharm Biomed Anal; 2008 Jan 07; 46(1):121-6. PubMed ID: 18022778 [Abstract] [Full Text] [Related]
10. Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats. Wei B, Li Q, Su D, Fan R, Zhao L, Geng L, He B, Chen X, Jia Y, Bi K. J Pharm Biomed Anal; 2013 Apr 15; 77():120-7. PubMed ID: 23416367 [Abstract] [Full Text] [Related]
11. Dibenzocyclooctadiene lignans from Fructus Schisandrae Chinensis improve glucose uptake in vitro. Zhang J, Shi LL, Zheng YN. Nat Prod Commun; 2010 Feb 15; 5(2):231-4. PubMed ID: 20334133 [Abstract] [Full Text] [Related]
12. [Rapid identification of the different constituents in Fructus Schisandrae Chinensis before and after processing by UHPLC-QTOF/MS~E combining with metabonomics]. Li W, Song YG, Liu KY, Yang LJ, Liu YL, Su D, Feng YL. Yao Xue Xue Bao; 2016 Sep 15; 51(9):1445-50. PubMed ID: 29924538 [Abstract] [Full Text] [Related]
13. Analysis of Schisandra chinensis and Schisandra sphenanthera. Lu Y, Chen DF. J Chromatogr A; 2009 Mar 13; 1216(11):1980-90. PubMed ID: 18849034 [Abstract] [Full Text] [Related]
14. Schisandra chinensis-dependent myocardial protective action of sheng-mai-san in rats. Li PC, Poon KT, Ko KM. Am J Chin Med; 1996 Mar 13; 24(3-4):255-62. PubMed ID: 8982437 [Abstract] [Full Text] [Related]
15. Analysis of lignans in Schisandra chinensis and rat plasma by high-performance liquid chromatography diode-array detection, time-of-flight mass spectrometry and quadrupole ion trap mass spectrometry. Lou Z, Zhang H, Gong C, Zhu Z, Zhao L, Xu Y, Wang B, Zhang G. Rapid Commun Mass Spectrom; 2009 Mar 13; 23(6):831-42. PubMed ID: 19222029 [Abstract] [Full Text] [Related]
16. Bioanalytical assay development and validation for simultaneous quantification of five schisandra lignans in rat primary hepatocytes based on LC-MS/MS: application to a real-time uptake study for Schisandra Lignan Extract. Kang D, Shao Y, Yin X, Xiao J, Rao T, Shen B, Chen H, Zhu Z, Wang G, Liang Y. Biomed Chromatogr; 2017 Feb 13; 31(2):. PubMed ID: 27459903 [Abstract] [Full Text] [Related]
17. Schizandrin reverses memory impairment in rats. Egashira N, Kurauchi K, Iwasaki K, Mishima K, Orito K, Oishi R, Fujiwara M. Phytother Res; 2008 Jan 13; 22(1):49-52. PubMed ID: 17705144 [Abstract] [Full Text] [Related]
20. [High performance preparation and structural confirmation of lignans from Schisandrae chinensis fructus by using HSCCC combined with ESI-MSn method]. Yu XL, Pi ZF, Hu XL, Song FR, Liu ZQ. Yao Xue Xue Bao; 2014 Jan 13; 49(1):78-82. PubMed ID: 24783510 [Abstract] [Full Text] [Related] Page: [Next] [New Search]